Parcharee Tivitmahaisoon

USPTO Granted Patents = 14 (Patent Applications = 8)

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 10)

Average Co-Inventor Count = 9.7

ph-index = 2

Forward Citations = 12(Granted Patents)

Location History:

San Francisco, CA (US) (2020 - 2022)
Boston, MA (US) (2016 - 2024)
South San Francisco, CA (US) (2024)

Company Filing History:

6 out of 13

Rapt Therapeutics, Inc.

patents

4 out of 2,076

Janssen Pharmaceutica Nv

patents

3 out of 527

Eisai R&d Management Co., Ltd.

patents

4. 1 out of 3

Yumanity Therapeutics, Inc.

patents

Years Active: 2016-2025

Loading Chart...

14 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12275723 - Compounds and uses thereof (2025-04-14),

2. 12240837 - Chemokine receptor modulators and uses thereof (2025-03-04),

3. 12180221 - Compounds and uses thereof (2024-12-31),

4. 12098139 - Chemokine receptor modulators and uses thereof (2024-09-24),

5. 11970486 - Compounds and uses thereof (2024-04-30),

6. 11926619 - Certain pladienolide compounds and methods of use (2024-03-12),

7. 11918582 - Pyrazole pyrimidine compounds and uses thereof (2024-03-05),

8. 11873298 - Compounds and uses thereof (2024-01-16),

9. 11384064 - Chemokine receptor modulators and uses thereof (2022-07-12),

10. 11192879 - Chemokine receptor modulators and uses thereof (2021-12-07),

11. 10919885 - Compounds and uses thereof (2021-02-16),

12. 10745387 - Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(piridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-1-carboxylate and methods of use thereof (2020-08-18),

13. 10683280 - Chemokine receptor modulators and uses thereof (2020-06-16),

14. 9481669 - Pladienolide pyridine compounds and methods of use (2016-11-01),

Title: Parcharee Tivitmahaisoon: A True Pioneer in the World of Inventions

Introduction:

Parcharee Tivitmahaisoon, a distinguished inventor based in Boston, MA (US), has established himself as a trailblazer in the realm of innovation. With a passion for pushing the boundaries of what is possible, he has become renowned for his relentless pursuit of groundbreaking discoveries.

Latest Patents:

Tivitmahaisoon's latest patents showcase his remarkable contributions to the field of science and medicine. The first patent revolves around "Compounds and uses thereof," highlighting the development of compounds for the treatment of neurological disorders. The second patent focuses on "Pladienolide compounds and methods of use," showcasing novel therapeutic agents for the treatment of cancers, particularly those affected by mutations in the spliceosome.

Career Highlights:

Throughout his career, Tivitmahaisoon has demonstrated a keen interest in research and development. He has worked with esteemed companies such as Eisai R&D Management Co., Ltd., and Janssen Pharmaceutica NV, where he has contributed significantly to the advancement of pharmaceutical innovation. With a total of six patents to his name, he has cemented his status as a leading figure in the innovation landscape.

Collaborations:

Collaboration has been a key aspect of Tivitmahaisoon's success. Working alongside accomplished professionals such as Gregg F Keaney and John Wang, he has been able to leverage a diverse range of expertise to drive forward his inventions. These collaborative efforts have not only enriched his work but have also led to the development of groundbreaking solutions in the field of medicine.

Conclusion:

In conclusion, Parcharee Tivitmahaisoon's unwavering commitment to innovation and his visionary approach to invention have established him as a true pioneer in his field. With a string of patents and a legacy of groundbreaking discoveries, he continues to inspire and shape the future of scientific exploration.

This text is generated by artificial intelligence and may not be accurate.